Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2

BACKGROUND: Rigors are a significant adverse event during interleukin-2 (IL2) therapy for metastatic melanoma and renal cell carcinoma. Meperidine has been a mainstay for rigor prophylaxis but there is a paucity of data regarding possible alternatives. METHODS: Ninety one patients receiving IL2 ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Khong, Brian, Lawson, Benjamin O., Ma, Junjie, McGovern, Cheryl, Van Atta, Joan K., Ray, Abhijit, Khong, Hung T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195987/
https://www.ncbi.nlm.nih.gov/pubmed/30342473
http://dx.doi.org/10.1186/s12885-018-4810-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195987/
https://www.ncbi.nlm.nih.gov/pubmed/30342473
http://dx.doi.org/10.1186/s12885-018-4810-y

Ejemplares similares